This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Redx Pharma Plc
Drug Names(s): RXC 004, RXC-004, Porcupine Inhibitor
Description: RXC004 is a novel small molecule inhibitor of the Porcupine (Porc) protein in the Wnt pathway. Wnt signalling is implicated in the maintenance of cancer stem cells. It will have the potential to be taken orally by patients as a once daily dose.
Additional information available to subscribers only: